GoDubai
  
  
  
  
Citylife > Press Release
  Home Contact us Add to Favourites
Most Recent Postings
More Press Releses
Featured Sections

Event Finder
A daily roundup of exhibitions, promotions and other events in Dubai and the rest of the Emirates.
Submit an Event
Latest Dubai Press Releases >> Healthcare, Fitness and Medicine

 
  Share
  • UAE is among the first countries in the world to introduce the first targeted biologics
  • The incidence of atopic dermatitis has increased by 2- to 3-fold during the past decades in industrialized countries 
Dubai, UAE, 11 March 2018 –   Under the patronage of the Emirates Dermatology Society, Sanofi today announced the launch of an innovative therapy, that is seen to significantly help adults with moderate-to-severe atopic dermatitis (AD). After receiving a fast-track approval by the Ministry of Health & Prevention, UAE is one of the first few countries in the world to make the therapy available to patients. 
 
“Launching healthcare innovations in the UAE is high on the agenda of the Ministry of Health & Prevention, and we have taken significant steps in the past years to accelerate availability of innovations and breakthrough that improve people's life and enhance their happiness. We are indeed driven by the vision of our beloved country leaders who want people living in our beautiful country to enjoy highest standards of life,” said His Excellency Dr. Amin Al Amiri,  Asst. Undersecretary for Public Health Policy and License Sector in UAE Ministry of Health & Prevention. 
 
Atopic dermatitis, a form of eczema, is a chronic inflammatory disease with symptoms often appearing as a rash on the skin. , , ,  It is caused, in part, by an underlying inflammation in the body that is believed to be driven by an overactive immune system. Moderate-to-severe atopic dermatitis is characterized by rashes often covering much of the body, and can include intense, persistent itching and skin dryness, cracking, redness, crusting, and oozing. ,  Itch is one of the most difficult symptoms for patients and can be severely debilitating.7 In addition, they experience impaired quality of life, including disrupted sleep, and increased anxiety and depression symptoms along with their disease. 
 
“People with moderate-to-severe atopic dermatitis can experience unbearable symptoms. Most of them endure uncontrollable itch and bleeding lesions. So, to say that this condition negatively impacts their quality of life is an understatement,” said Dr. Anwar Al Hammadi, Consultant and Head of Dermatology at Dubai Health Authority and President of Emirates Dermatology Society. “Patients struggle to effectively control their disease with the treatment options currently available.”
 
The new therapy  introduced is jointly developed by Sanofi and Regeneron under a global collaboration agreement. It is a first-in-class biologic medicine approved by the European Commission (EC) to treat adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.  The EC approval of the medicine was based on data from the global LIBERTY AD clinical trial program that included approximately 2,800 adults living with this serious disease.      It has demonstrated a significant reduction in the signs and symptoms of the disease and improvement in quality of life. 
 
“As physicians, we welcome the timely access to this important new medication to help provide patients relief from this severely debilitating condition. As members of the UAE society, we all have a vital role to play towards raising more awareness; and hence, creating better understanding of what people with the condition go through,” added Dr. Al Hammadi.
 
Attendees at the press conference launch had the unique opportunity to experience the impact of atopic dermatitis through an art installation that captured an emotional journey through testimonials, real feelings and stories of people living with the condition. 
 
The announcement comes ahead of the medical launch of the innovative therapy for healthcare professionals on 9 March. It is expected to be attended by leading dermatologists in the country, along with global and regional experts.
 
“At Sanofi, it remains a key priority for us to bring first to the country innovative treatments, and to make sure that the most number of people to have access to them. The efforts of the UAE Ministry of Health to accelerate availability of new innovative treatments for the patients in the UAE is, indeed, remarkable,” said Jean Paul Scheuer, Country Chair and General Manager for Sanofi Gulf. The introduction of this therapy is an important milestone for people living with moderate-to-severe atopic dermatitis in UAE. 



Posted by : GoDubai Editorial Team
Viewed 13505 times
Posted on : Sunday, March 11, 2018  
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of GoDubai.com.
Previous Story : Spotlight on technological advancements at the 6th International Congress for Joint Reconstruction M...
Next Story : Arabian Healthcare Group and Dignity Health USA team up to expand world-class clinical excellence to...
Email this article Print this article

Share this article with your friends and followers
NewsVine

Comments

Back to Top  
Most Viewed Press Release posted in the last 7 days
Let It Glow
Filorga Launches FLASH-NUDE Collection
Let All Your Photos Be Merry & Bright
The Rado DiaMaster Petite Seconde Automatic COSC The Rado watch at the top of th...
HP ProBook x360 11 G3 and G4 Education Edition
Chrono 4 Grande Taille - an extra-special timepiece
30 Years of Ryder Cup Heroes Confirmed for the 30th Edition of the Omega Dubai ...
Maintain Healthy Skin Year Round
PopSockets launches a new collection with crystals from Swarovski, the must-have...
Free gold coins at Malabar Gold & Diamonds Festival
MIDO Baroncelli Lady Day & Night collection
American Eagle Is the Go-to Destination for Gifting This Holiday Season'
Golden Mile Galleria's ‘A Cultural Flair' attracts hundreds of art lovers to Pal...
The Interiors Gift Guide with Home and Soul
Newby Teas Launches Advent Calendar For Christmas 2018
GAZOO Racing Wins Australia Rally at FIA World Rally Championship
Tissot Chemin des Tourelles
24 Karat Gold Elixir by Mehrunisa Launches in the UAE Beauty Market
Growth and inclusivity drive Avaya's channel strategy for 2019
Get Ready for Party Season with Lottie's new make-up hits
Time For Enchanting Moments
Interview with Asil Attar, CEO of Al Yasra Fashion
Festive Gift Sets from Bubble T
Holiday Handbags | GUESS
Holiday Gifting Made Easy with Wet n Wild Beauty Specials
BharatMatrimony launches office in Dubai targeting 2 Million Indians
Tissot PR100 Lady Sport – Chic Glamourous Festive Season
Winter wool Christmas must- haves
Michael Kors Collection Transeason 2019 Press Presentation
New 1948 Seamaster Watches Join the Ranks'
Samsung Galaxy A9 – Designed to capture the world in its fullest
Five-Star Euro NCAP for Jaguar's Electric I-PACE
France Attractiveness Scoreboard 2018 Released
Global Knowledge Index 2018 and The Future of Knowledge: A Foresight Report shin...
UOWD's quality management expert wins ASQ-UAE Quality Professionals Award
Dubai's Most Magical Festive Market Opens at Dubai Festival City Mall
Ring in a dazzling festive season at Ibn Battuta Mall
Tissot PR100 Lady Sport – Chic Sporty yet Feminine
Chinese Manufacturing Companies to Highlight Trade Opportunities in Middle East
Dubai Customs wins 3 awards from Ideas UK 2018
FBMA and 47 Emirati women celebrate UAE National Day
New ACH145 Mercedes-Benz Style Cabin Model Highlights First Presence at MEBAA fo...
Spinneys Dubai 92 Cycle Challenge | Road Closure Timings
Jury Announced for Epson's First Ever Win-A-Robot Competition in Europe, The Mid...
Raja Al Gurg is one of Forbes Magazine's 100 most powerful women in the world
Al Hosn Now Open to the Public
Chic and Stylish Wraps with a 3 in 1 effortless concept
New Menu alert: Moombai & Co. launches exciting and delicious food items to its menu
ICAEW recognises Middle East's best finance professionals
Voting on UAE Superbrands 2019 Begins